Triatec and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triatec (ramipril) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include thrombocytopenia among females and hyponatraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Triatec and Gaviscon. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Triatec?

Triatec has active ingredients of ramipril. eHealthMe is studying from 4,133 Triatec users. Check the latest studies of Triatec.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

On Aug, 01, 2026

25 people who take Triatec and Gaviscon together, and have interactions are studied.

What are the common drug interactions of Triatec and Gaviscon, by gender? *:

female:

Thrombocytopenia (decrease of platelets in blood)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Migraine with aura (headache with vision weakness)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Sensorimotor disorder (disease of sensory and motor function of brain)
Bone marrow failure
Cardiomyopathy (weakening of the heart muscle)
Coma (state of unconsciousness lasting more than six hours)
Dyspnoea (difficult or laboured respiration)

male:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Dehydration (dryness resulting from the removal of water)
Decreased appetite
Mucosal dryness (dryness of mucous membrane)
Arthralgia (joint pain)
Back pain
Delirium (wild excitement)
Hyperthermia (body temperature greatly above normal)
Lung infection
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Triatec and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Angioedema (rapid swelling of the dermis)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Decreased appetite
Malaise (a feeling of general discomfort or uneasiness)
Mucosal dryness (dryness of mucous membrane)
Migraine with aura (headache with vision weakness)

50-59:

Eosinophilia (eosinophil count in the peripheral blood exceeds)
Hepatocellular injury (liver injury)
Neutropenia (an abnormally low number of neutrophils)

60+:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Thrombocytopenia (decrease of platelets in blood)
Cardiomyopathy (weakening of the heart muscle)
Coma (state of unconsciousness lasting more than six hours)
Dyspnoea (difficult or laboured respiration)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Fall
Haemoglobin decreased
Head injury
Hypertension (high blood pressure)

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 28.00%
Pain: 5 people, 20.00%
Neuralgia (pain in one or more nerves): 5 people, 20.00%
Insomnia (sleeplessness): 4 people, 16.00%
Infected Skin Ulcer: 3 people, 12.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Triatec and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously